m.MaruANIMAL HOSPITALHome ↗

MARU / PROFESSIONAL PARTNERSHIP

Connecting hospital to hospital,
toward the next step in treatment and testing.

Information for domestic partners and overseas buyers.
Introducing our treatment systems, testing services, training and adoption structure.

PARTNERSHIP RESOURCES

Partnership Resources

View the Korean business plan and attachments as PDFs.

View Partnership Resources ↗
Produced image of a clinical and testing discussion · not actual Maru staff or a concluded partnership
Produced image of a clinical and testing discussion · not actual Maru staff or a concluded partnership

FOR DOMESTIC & INTERNATIONAL PARTNERS

What partners need to know:
Maru’s proposal.

Centered on veterinary care for companion animals, we present a partnership model that connects treatment systems, specialized testing, training and operational support. For hospitals in Korea we explain clinical and testing collaboration; for overseas buyers, an adoption structure operated together with local hospitals.

This is the partnership model presented in our business plan.

The following describes the scope proposed in the plan. The products actually available, responsible organizations, usage rights, prices, local permits and contracts are confirmed in adoption discussions. This does not mean that the plan’s descriptions of treatment effects have been independently verified.

Treatment systems

Chamber and related technology

The plan proposes placing life-energy and quantum-related treatment systems and the chamber in hospitals. Models, installation requirements, scope of application, safety data and maintenance are confirmed before adoption.

Testing services

Collection · Analysis · Report

We introduce the PetAge360 telomere test and the oral microbiome and cancer gene fields. Target animals, test items, sample requirements, reports and turnaround times are confirmed separately for each product.

Training and operations

Preparing to connect with clinical care

A training model covering equipment explanation, reading test results, the application process and progress records. Training scope, instructors, materials provided and follow-up support are discussed together.

Source: Korean business plan, p. 3 and pp. 12–16. Test names and functions are finally confirmed against the supplier’s current veterinary product materials.

DOMESTIC PARTNER CHECKLIST

For domestic partners,
clarity on the work each will actually do.

How partner hospitals get started

  • Discuss the areas needed first among referrals, testing collaboration, equipment adoption and training
  • Confirm the attending veterinarian, place of care, target animals and intake criteria
  • Agree on what runs alongside existing care, and on owner explanation, consent and follow-up care
  • Check the process from intake to returning results through small-scale operation

Checklist for supply and operations partners

  • Contracting parties and supply authority; equipment ownership and rental terms
  • Supply of kits and consumables; equipment installation, inspection and breakdown response
  • Testing, procedure, training and logistics fees, and settlement responsibility
  • Handover in case of re-collection, refunds, delays, staff absence or contract termination

The success of a partnership is measured not by the number of hospitals but by whether actual clinical connections, completed tests, explanations of results and follow-up care continue. Operational checks do not replace verification of treatment effects.

Source: Comprehensive document, Implementation sections 6, 8, 9 and 10. This is a practical summary for domestic partnerships, not confirmed contract terms.

INTERNATIONAL BUYER / OPERATING MODEL

For overseas buyers:
what to adopt, and how.

1. Two pillars of adoption

The plan proposes placement of treatment systems at local hospitals, and sample collection, analysis in Korea and report return, as two separate tracks. Starting with testing services can also be considered; the scope and schedule of equipment adoption and testing operations are discussed separately.

2. Roles in Korea and locally

PartyRole proposed in the planPoints to agree in practice
Maru / Korean supply and analysis sideTreatment systems and related consumables, analysis in Korea, technical and report trainingSupplier, analysis lab and trainer; documents provided; quality and support responsibilities
K-LinkFinding local partners, regional negotiations and business coordinationActual participation in contracts, agency authority, roles and point of contact
Local branch / buyerHospital network, local adoption procedures, supply, sales, settlement and after-sales supportTerritory, legal entity, facilities, operational capacity and cost sharing
Local animal hospitals and veterinariansTreating patients, collecting samples, explaining results and managing follow-upLocal practice licensing, medical responsibility and owner consent

3. Linking samples and results

  1. Collected at local hospitals

    Samples are collected according to each product’s guidelines and linked to the animal’s information and an intake number.

  2. Transported to the analysis lab in Korea

    Whether export and import are permitted, as well as storage, packaging, shipping and sample acceptance criteria, are confirmed first.

  3. Analysis and report

    The actual lab, test method, criteria and limitations, and expected result date are confirmed.

  4. Results returned locally

    Explanations in the local language are linked with the attending veterinarian’s interpretation and follow-up care.

4. Training and technical support

The plan proposes that local veterinarians receive training in Korea in theory, equipment, hands-on practice and report reading, and then apply it in local operations. Listed training topics include telomere-related protocols, microcirculation, light fusion and gold thread, and PetAge360 report reading. The courses actually available, qualifications and usage rights, interpreting, duration, costs and after-sales support are agreed separately.

5. Adoption costs and regional rights

The plan’s cost and revenue structure consists of equipment supply or rental, per-test fees, consumables, and training and support. Amounts, revenue-sharing ratios and minimum operating volumes are not presented as fixed figures. Retesting intervals are likewise set according to product evidence and the veterinarian’s judgment, and recurring revenue is not guaranteed.

Regional branches and conditional exclusivity and recruitment rights are proposals in the plan. Whether rights cover a whole country or a specific region, as well as their term, products, performance conditions, renewal, termination and resale rights, are confirmed in the contract. Because the plan mentions sale, rental and free rental as equipment supply methods, final ownership, custody and return terms must be negotiated.

Source: Korean business plan, p. 12 (products and adoption), p. 13 (sample cycle), pp. 14–15 (organizations, regional rights and training), p. 18 (cost and revenue structure). The above does not confirm any local permit or supply contract.

FROM REVIEW TO PILOT

From document review
to a local pilot.

  1. Confirm the buyer’s region and capabilities

    Summarize the country, responsible entity, affiliated hospitals and veterinarians, products of interest and expected operating scale.

  2. Review adoption materials

    Review equipment specifications, safety and performance data, rights documents, veterinary test descriptions, anonymized reports, original case records and training scope. Patents are distinguished from certification of treatment effects.

  3. Agree on supply and local conditions

    Finalize quotes, logistics, permits, sample export and import, data handling, language, settlement and support responsibilities. We do not give blanket statements that permits are unnecessary in a particular country.

  4. Small-scale pilot operation

    Check the turnaround time for collection → intake → analysis → return, and the procedures for training, explanation and equipment support.

  5. Expand after reviewing results

    Review actual operating records and agree on contract scope, follow-up care and the next supply.

Information needed for the first discussion

  • Country, city, company or hospital name, and contact person
  • Hospital network and whether local veterinarians will take part
  • Areas of interest among testing, equipment and training, and planned scale
  • Preferred schedule, document language, local logistics and adoption experience
  • Questions about regional rights, costs, training and support

Source: Korean business plan, pp. 19–21, and Comprehensive document, Implementation sections 5, 9 and 10. The quarterly schedule in the plan is a planned outline, not a confirmed delivery date or service launch date.

DOMESTIC HOSPITAL PARTNERS

Starting with hospitals in Korea:
clinical and testing partnerships.

We discuss together how to connect Maru’s core treatments and specialized testing partnerships to the clinical workflow of other animal hospitals. We distinguish treatment referrals from testing collaboration, and aim for a structure in which roles between hospitals and explanations to owners connect smoothly.

A partnership starts not by increasing the number of hospitals but by defining the work each will actually take on. After agreeing specifically on target animals, areas to be provided, referral and feedback methods and follow-up care, we review the process on a small scale.

Clinical partnership

Referral and feedback

We share the animal’s condition and the purpose of the referral, and pass the clinical details and next plan on to the responsible hospital.

Testing

Collection and analysis

We align sample and analysis criteria for each product, the delivery of results and the veterinarian’s explanation.

Training partnership

Explanation and records

We share materials for understanding test interpretation and real cases, operational explanations and methods for recording progress.

AREAS TO DISCUSS

Three partnership areas
to discuss together.

01

Core treatment collaboration

We discuss explanations of telomere, chamber and quantum-related treatment approaches and clinical referrals for individual animals. The actual scope of application and responsibilities are set specifically by the veterinarian and the party responsible for the technology or equipment.

Treatment details →
02

Testing service collaboration

We aim to connect telomere, oral microbiome, cancer gene and hereditary disease test information with the hospital’s consultations. Target animals and supply and analysis conditions for each product are set in actual discussions.

Testing details →
03

Training and case resource sharing

We discuss training and resource sharing covering the scope of interpreting test results, how to read cases, and referral, result delivery and progress records.

Case records →

CLEAR RESPONSIBILITIES

Clear roles
keep partnerships going.

PartyRole to discussWhat to align
Partner animal hospitalInitial examination and explanation, referral information and sample preparation, contact with ownersTarget animals, purpose of referral, attending veterinarian, follow-up care
Maru clinical teamReviewing referrals, explaining the scope of care provided, returning clinical details and plansIntake criteria, place and schedule of care, feedback method
Testing lab / supplierKit guidelines, sample suitability, analysis, reports and test inquiriesAnalysis items, shipping, turnaround and re-collection conditions
Coordination contactCommunication between organizations, status checks and agreed operating recordsPoint of contact, handover, and response to delays or interruptions

These are role divisions to be agreed in partnership design. Each organization’s actual responsibilities and contract terms are set through the relevant discussions.

CLINICAL REFERRAL & FEEDBACK

From referral to feedback,
we connect clinical information.

What to share when referring

  • The animal’s basic information and current symptoms
  • Previous tests, imaging and clinical records, and current medications
  • Purpose of the referral and the attending veterinarian’s questions
  • What has been explained to the owner and the scope of consent

What to carry forward in the feedback

  • Findings from the examination and treatments applied
  • Items to watch in concurrent care and follow-up observation
  • Follow-up care plan and each hospital’s responsibilities
  • Next contact and how to check the animal’s condition

We define what the referring hospital and the treating hospital each need to know. This is not a process that leads automatically to a specific treatment; a veterinarian reviews whether it applies to each animal.

TESTING WORKFLOW

Until each test is complete,
we align every step together.

  1. Explain the purpose and target of the test.

    The hospital and testing staff agree on test items, limitations, preparation and the scope of cost explanations.

  2. Collect and ship according to each product’s guidelines.

    Samples are accurately matched with referral information, and storage, shipping and intake requirements are followed.

  3. Confirm intake and results with the analysis lab.

    Sample suitability, expected result timing and the procedure if re-collection is needed are shared among the staff involved.

  4. Explain the report together with clinical information.

    The lab’s explanation of the analysis and the veterinarian’s clinical judgment are kept distinct when explaining to the owner.

  5. Continue observation and handle inquiries.

    Determine whether the owner understood the results, whether further consultation or care is needed, and who will handle follow-up questions.

Costs and operating terms are agreed as well.

We discuss the supply, analysis and explanation scope for each product, cost sharing, re-collection, cancellation and refunds, and who is responsible for contact if results are delayed. This page does not present any unconfirmed terms of use.

TRAINING & SHARED MATERIAL

Sharing resources,
aligning how we explain.

Understanding tests

Purpose · Measurement · Interpretation

Covers what each test measures, report structure, the scope of interpretation and owners’ questions.

Understanding cases

Types of records

We share how to explain cases by distinguishing hospital explanations, photos, tests and clinical records.

Understanding operations

Step-by-step practice

We align on referral, collection, intake, result delivery, progress records and handover between organizations.

Training on technologies or equipment follows the scope permitted by the rights holders and responsible experts. Sharing materials or taking part in training is not described as automatically granting usage rights or qualifications for any specific technology.

PARTNERSHIP STEP BY STEP

Partnership,
one concrete step at a time.

  1. Tell us your hospital’s needs and areas of interest.

    We narrow down which work is needed first: referrals, testing collaboration or training.

  2. Align on scope and responsibilities.

    We confirm the actual staff, the scope of care, analysis and supply, and schedules, contacts and terms.

  3. Review the process on a small scale.

    We check that everything connects from intake to results and feedback, and that the work and owner explanations run without difficulty.

  4. Review records and improve the process.

    We sort out issues with delays, re-collection, inquiries and handover, and apply the lessons to the next round.

  5. Expand the partnership within the confirmed scope.

    Expansion is discussed based on whether the actual work and responsibility structure hold up.

Small-scale operational checks and clinical research to verify treatment effects have separate purposes and procedures.

INTERNATIONAL PARTNER DIRECTION

Connections built in Korea,
together with local hospitals.

Our international partnerships are directed toward a partner structure centered on local animal hospitals and veterinarians. Going beyond translating our Korean materials, we define roles to fit local clinical, analysis, supply and explanation processes.

What we prepare on the Korean side

We organize clinical, testing and case materials that can be disclosed, roles by organization, training and operational explanations, and the agreed scope of supply and contact.

What to align with local partners

We discuss target animals and products, local clinical responsibility, language and result explanation, sample handling and supply methods, and follow-up care and inquiry handling.

Clinical, testing, shipping, product and data-handling requirements in each country must be confirmed according to the actual targets and methods. We do not present contracts, exclusive rights or local services in any specific country as already confirmed.

PREPARE FOR A CONVERSATION

Preparing before we talk
makes the discussion more concrete.

  • Hospital name, region, attending veterinarian and business contact
  • Areas of interest: referrals, testing, training, international partnership
  • Work you want to connect with your current clinical workflow
  • Target animals and expected operating scope
  • Staff responsible for samples, reports and owner explanations
  • Questions to confirm first on schedule, supply, costs and responsibilities

General partnership discussions do not require sharing individual medical records in bulk. At the actual referral stage, the necessary information and scope of consent are defined before anything is shared.

QUESTIONS & ANSWERS

Common questions
when discussing a partnership.

Can we discuss only the testing partnership first?+

Discussions can start with the specific area you are interested in. Testing collaboration and clinical and treatment partnerships each have their own scope and responsibilities.

Can we use the equipment right after training?+

Training is separate from equipment supply and usage rights. The actual application of equipment, responsibilities and required conditions must be set separately by the responsible experts and rights holders.

What is confirmed first in a partnership between hospitals?+

We first confirm the purpose of the referral, the scope of testing, result delivery and owner explanations. Costs and cancellation and refund terms require agreement between the organizations before actual work begins.

Are nationwide branches or overseas exclusive rights included?+

Business cooperation between hospitals is separate from regional, exclusive or supply rights. The scope, term, subject and responsibilities of any rights must be agreed separately.

Do we need to handle many cases from the start?+

The approach is to first agree on scope and responsibilities, then confirm on a small scale that intake, analysis, feedback and explanation connect smoothly.

Top